ALLK: Allakos Inc. Stock

by  •  • Comments Off on ALLK: Allakos Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 29.81
Enterprise Value ($M) 5.58
Book Value ($M) 55.46
Book Value / Share 0.61
Price / Book 0.54
NCAV ($M) 54.01
NCAV / Share 0.60
Price / NCAV 0.55

Profitability (mra)
Return on Invested Capital (ROIC) -1.28
Return on Assets (ROA) -0.40
Return on Equity (ROE) -0.68

Liquidity (mrq)
Quick Ratio 14.23
Current Ratio 14.23

Balance Sheet (mrq) ($M)
Current Assets 58.09
Assets 59.55
Liabilities 4.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -118.76
Net Income -115.82
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -93.62
Cash from Investing 44.76
Cash from Financing 0.18

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-17 13D/A Tang Capital Management Llc 9.60 0.00
04-09 13G Beryl Capital Management LLC 8.90
11-12 13G Fmr Llc 6.04 279.40
07-08 13G/A BlackRock, Inc. 1.40 -75.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2025-04-17 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One)
2025-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 5,419 151,302 3.58
2025-05-08 21,004 265,283 7.92
2025-05-07 71,560 378,800 18.89
2025-05-06 99,201 629,766 15.75

(click for more detail)

Similar Companies
AKRO – Akero Therapeutics, Inc. ALEC – Alector, Inc.
ALKS – Alkermes plc ALLO – Allogene Therapeutics, Inc.
ALNY – Alnylam Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io